Key Trend Reshaping the Veterinary Oncology Market in 2025: Innovative Approaches to Cancer Vaccines

What Are the Projections for the Size and Growth Rate of the Veterinary Oncology Market?
In recent times, there has been a significant expansion in the size of the veterinary oncology market. The sector is expected to escalate from a value of $0.4 billion in 2024 to $0.45 billion the following year, with a compound annual growth rate (CAGR) of 12.3%. The past increase in this market may be credited to factors like rising pet adoption, the humanization of pets, applications of knowledge from human oncology, enhanced cognizance about pet health and advancements in pharmaceuticals.

In the coming years, the size of the veterinary oncology market is projected to witness swift expansion. The market value is estimated to reach $0.69 billion by 2029, with an 11.0% compound annual growth rate (CAGR). This growth over the forecast period is due in part to factors such as the rise of personalized medicine for animals, an increase in animal cancer prevalence, a growth in the aging pet population, more widespread availability of specialized care, and regulatory support coupled with approvals. Looking forward, major market trends include improved diagnostic technologies, bespoke treatment strategies, advances in immunotherapy, targeted therapeutic methods, and the adoption of telemedicine for oncology consultations.

What Are the Main Catalysts for Growth in the Veterinary Oncology Market?
An upward trend in pet cancer is predicted to drive the growth of the veterinary oncology market. This pertains to diseases where some of the animal's cells proliferate uncontrollably and metastasize to other parts of the body. Essentially, pet cancer constitutes the physical display of a tumor, like swelling. The realm of veterinary oncology is devoted to the diagnosis and treatment of animal cancer, with the aim of minimizing the spread of the disease and metastasis. Consequently, a surge in pet cancer directly enhances the demand for veterinary oncology. For example, a 2024 forecast from The Cancer Letter, an American publication focusing on cancer research, predicts that about 6 million pet dogs in the U.S. will be diagnosed with cancer. Further, according to a prognosis by the British Small Animal Veterinary Association (BSAVA), a veterinary association based in the U.K., it is estimated that by November 2023, around 1 in 4 dogs and 1 in 5 cats will suffer from cancer at some point in their lifetime. As such, the escalating incidences of cancer in pets are stimulating the expansion of the veterinary oncology market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Which Businesses Are at the Forefront of Veterinary Oncology Market Development?
Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

What Are the Latest Innovations in the Veterinary Oncology Market?
Primary businesses in the veterinary oncology market are concentrating their efforts on the creation of neoantigens, distinctive antigens generated from mutations within cancer cells exclusive to tumors. Unlike conventional antigens, neoantigens result from genetic alterations within the DNA of the tumor. For example, a US-based biotech company initiated a cancer vaccine trial for dogs in October 2024. The study and incorporation of neoantigens in the creation of cancer vaccines and various immunotherapies is underway, aiming to boost the immune response particularly towards cancer cells, while keeping normal cells unharmed.

How Is the Veterinary Oncology Market Segmented?
The veterinary oncology market covered in this report is segmented -

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies
2) By Animal Type: Equine, Canine, Feline, Other Animal Types
3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:
1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation
2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques
3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents
4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Where Is the Veterinary Oncology Market Growth Most Prominent?
The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Is Covered In The Veterinary Oncology Global Market Report?

- Market Size Analysis: Analyze the Veterinary Oncology Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Veterinary Oncology Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Veterinary Oncology Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Veterinary Oncology Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.